Traders Purchase High Volume of Call Options on SIGA Technologies (NASDAQ:SIGA)

SIGA Technologies, Inc. (NASDAQ:SIGA) was the target of unusually large options trading on Wednesday. Traders purchased 1,200 call options on the stock. This represents an increase of 1,438% compared to the typical daily volume of 78 call options.

Institutional Investors Weigh In On SIGA Technologies

Several hedge funds have recently bought and sold shares of the company. Wellington Management Group LLP bought a new stake in SIGA Technologies during the 3rd quarter worth approximately $757,000. AltraVue Capital LLC increased its position in shares of SIGA Technologies by 6.6% during the second quarter. AltraVue Capital LLC now owns 2,177,646 shares of the company’s stock worth $16,528,000 after acquiring an additional 134,450 shares in the last quarter. Hotchkis & Wiley Capital Management LLC raised its holdings in shares of SIGA Technologies by 152.6% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 2,048,440 shares of the company’s stock worth $13,827,000 after acquiring an additional 1,237,620 shares during the period. Harbor Capital Advisors Inc. acquired a new stake in shares of SIGA Technologies during the third quarter worth $1,098,000. Finally, Foundry Partners LLC bought a new stake in SIGA Technologies in the 3rd quarter valued at $2,801,000. 55.40% of the stock is currently owned by institutional investors and hedge funds.

SIGA Technologies Trading Down 0.2 %

NASDAQ SIGA opened at $6.28 on Friday. SIGA Technologies has a 12 month low of $4.26 and a 12 month high of $12.83. The stock has a 50-day simple moving average of $6.55 and a 200 day simple moving average of $7.62. The company has a market capitalization of $448.42 million, a PE ratio of 5.23 and a beta of 0.94.

SIGA Technologies (NASDAQ:SIGA) last announced its quarterly earnings results on Thursday, November 7th. The company reported $0.02 EPS for the quarter. SIGA Technologies had a return on equity of 49.06% and a net margin of 49.33%. The company had revenue of $10.01 million during the quarter. As a group, sell-side analysts predict that SIGA Technologies will post 1.04 earnings per share for the current fiscal year.

SIGA Technologies Company Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.